GlassScriptPhysician profile
Felipe Gracias
NPI 1841289709
$23,059.17
in general payments reported to CMS, 2019-2025
11 companies · $2,061 in 2025
The $2,061 reported for 2025 was more than what 80% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,702 · 2020: $11K · 2021: $5,398 · 2022: $25.76 · 2023: $148 · 2024: $685 · 2025: $2,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,786 · Travel and Lodging: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,786.27 |
| Travel and Lodging | $1,107.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $11,834.93 | 2019-2020 | |
| Intuitive Surgical, INC. | $6,694.81 | 2019-2024 | |
| Davol INC. | $3,010.91 | 2019-2025 | Phasix Mesh |
| Medtronic, INC. | $901.46 | 2021 | |
| Endologix LLC | $270.19 | 2021 | |
| Baxter Healthcare | $121.38 | 2021-2025 | Perclot |
| Bioventus LLC | $120.39 | 2024 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $43.72 | 2021 | |
| Leica Microsystems INC. | $35.62 | 2021 | |
| Aroa Biosurgery Incorporated | $21.79 | 2022 | |
| Thd America, INC. | $3.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felipe Gracias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.